$GILD Remdesivir has met the primary endpoint in a trial of its effectiveness in treating #COVID19. The drug could get an US FDA approval on the flip of a coin. This is an opinion.  $XBI $IBB $SPY $SPX #DJIA $DIA #DOW #NASDAQ 

https://t.co/9jDKycn84z